What are you looking for today?

Karagkiozaki, Varvara, Vavoulidis, Eleftherios, Karagiannidis, Panagiotis, Gioti, Maria, Fatouros, Dimitrios, Vizirianakis, Ioannis and Logothetidis, Stergios (2012) Development of a nanoporous and multilayer drug-delivery platform for medical implants. International Journal of Nanomedicine, 7. pp. 5327-5338. ISSN 1178-2013

Document

  • [thumbnail of 12 IJN-31185-development-of-nanoporous-and-multilayer-drug-delivery-platf_100512.pdf]
    12 IJN-31185-development-of-nanoporous-and-multilayer-drug-delivery-platf_100512.pdf - Published Version

Abstract

Abstract

Biodegradable polymers can be applied to a variety of implants for controlled and local drug delivery. The aim of this study is to develop a biodegradable and nanoporous polymeric platform for a wide spectrum of drug-eluting implants with special focus on stent-coating applications. It was synthesized by poly(DL-lactide-co-glycolide) (PLGA 65:35, PLGA 75:25) and polycaprolactone (PCL) in a multilayer configuration by means of a spin-coating technique. The antiplatelet drug dipyridamole was loaded into the surface nanopores of the platform. Surface characterization was made by atomic force microscopy (AFM) and spectroscopic ellipsometry (SE). Platelet adhesion and drug-release kinetic studies were then carried out. The study revealed that the multilayer films are highly nanoporous, whereas the single layers of PLGA are atomically smooth and spherulites are formed in PCL. Their nanoporosity (pore diameter, depth, density, surface roughness) can be tailored by tuning the growth parameters (eg, spinning speed, polymer concentration), essential for drug-delivery performance. The origin of pore formation may be attributed to the phase separation of polymer blends via the spinodal decomposition mechanism. SE studies revealed the structural characteristics, film thickness, and optical properties even of the single layers in the triple-layer construct, providing substantial information for drug loading and complement AFM findings. Platelet adhesion studies showed that the dipyridamole-loaded coatings inhibit platelet aggregation that is a prerequisite for clotting. Finally, the films exhibited sustained release profiles of dipyridamole over 70 days. These results indicate that the current multilayer phase therapeutic approach constitutes an effective drug-delivery platform for drug-eluting implants and especially for cardiovascular stent applications.

Item Type: Article
Depositing User: Panagiotis Karagiannidis
URI: https://sure.sunderland.ac.uk/id/eprint/7788

Further Details

More Information

Depositing User

Identifiers

Item ID
7788
Identification Number
ISSN
1178-2013

Users with ORCIDS

ORCID for Panagiotis Karagiannidis

Catalogue record

Date Deposited
21 Sep 2017 13:32
Last Modified
04 Jun 2025 15:27

Contributors

Author
Varvara Karagkiozaki
Author
Eleftherios Vavoulidis
Author
Maria Gioti
Author
Dimitrios Fatouros
Author
Ioannis Vizirianakis
Author
Stergios Logothetidis

University Divisions

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year